Literature DB >> 17976203

The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius.

A J Cameron1, P Z Zimmet, S Soderberg, K G M M Alberti, R Sicree, J Tuomilehto, P Chitson, J E Shaw.   

Abstract

AIMS: To assess the utility of the metabolic syndrome (MetS) and a Diabetes Predicting Model as predictors of incident diabetes.
METHODS: A longitudinal survey was conducted in Mauritius in 1987 (n = 4972; response 80%) and 1992 (n = 3685; follow-up 74.2%). Diabetes status was retrospectively determined using 1999 World Health Organization (WHO) criteria. MetS was determined according to four definitions and sensitivity, positive predictive value (PPV), specificity and the association with incident diabetes before and after adjustment for MetS components calculated.
RESULTS: Of the 3198 at risk, 297 (9.2%) developed diabetes between 1987 and 1992. The WHO MetS definition had the highest prevalence (20.3%), sensitivity (42.1%) and PPV (26.8%) for prediction of incident diabetes, the strongest association with incident diabetes after adjustment for age and sex [odds ratio 4.6 (3.5-6.0)] and was the only definition to show a significant association after adjustment for its component parts (in men only). The low prevalence and sensitivity of the International Diabetes Federation (IDF) and ATPIII MetS definitions resulted from waist circumference cut-points that were high for this population, particularly in men, and both were not superior to a diabetes predicting model on receiver operating characteristic analysis.
CONCLUSIONS: Of the MetS definitions tested, the WHO definition best identifies those who go on to develop diabetes, but is not often used in clinical practice. If cut-points or measures of obesity appropriate for this population were used, the IDF and ATPIII MetS definitions could be recommended as useful tools for prediction of diabetes, given their relative simplicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976203     DOI: 10.1111/j.1464-5491.2007.02288.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  The influence of hip circumference on the relationship between abdominal obesity and mortality.

Authors:  Adrian J Cameron; Dianna J Magliano; Jonathan E Shaw; Paul Z Zimmet; Bendix Carstensen; K George Mm Alberti; Jaakko Tuomilehto; Elizabeth L M Barr; Vassen K Pauvaday; Sudhirsen Kowlessur; Stefan Söderberg
Journal:  Int J Epidemiol       Date:  2012-01-22       Impact factor: 7.196

Review 2.  Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.

Authors:  Brian Buijsse; Rebecca K Simmons; Simon J Griffin; Matthias B Schulze
Journal:  Epidemiol Rev       Date:  2011-05-27       Impact factor: 6.222

3.  Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study.

Authors:  A Shah; A Hernandez; D Mathur; M J Budoff; A M Kanaya
Journal:  Int J Obes (Lond)       Date:  2011-08-23       Impact factor: 5.095

4.  Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study.

Authors:  Chia-Ing Li; Sharon Lr Kardia; Chiu-Shong Liu; Wen-Yuan Lin; Chih-Hsueh Lin; Yi-Dar Lee; Fung-Chang Sung; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  BMC Public Health       Date:  2011-10-17       Impact factor: 3.295

5.  Metabolic syndrome in the Mediterranean region: Current status.

Authors:  Panagiotis Anagnostis
Journal:  Indian J Endocrinol Metab       Date:  2012-01

Review 6.  Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.

Authors:  Jeong-Ah Shin; Jin-Hee Lee; Sun-Young Lim; Hee-Sung Ha; Hyuk-Sang Kwon; Yong-Moon Park; Won-Chul Lee; Moo-Il Kang; Hyeon-Woo Yim; Kun-Ho Yoon; Ho-Young Son
Journal:  J Diabetes Investig       Date:  2013-05-28       Impact factor: 4.232

7.  PCOS-GWAS Susceptibility Variants in THADA, INSR, TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance in Women With PCOS.

Authors:  Ye Tian; Jingyu Li; Shizhen Su; Yongzhi Cao; Zhao Wang; Shigang Zhao; Han Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-30       Impact factor: 5.555

8.  Subtypes of Premorbid Metabolic Syndrome and Associated Clinical Outcomes in Older Adults.

Authors:  Chu-Sheng Lin; Wei-Ju Lee; Shih-Yi Lin; Hui-Ping Lin; Ran-Chou Chen; Chi-Hung Lin; Liang-Kung Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-11

9.  Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.

Authors:  Earl S Ford; Matthias B Schulze; Tobias Pischon; Manuela M Bergmann; Hans-Georg Joost; Heiner Boeing
Journal:  Cardiovasc Diabetol       Date:  2008-12-12       Impact factor: 9.951

Review 10.  Metabolic syndrome and incident diabetes: current state of the evidence.

Authors:  Earl S Ford; Chaoyang Li; Naveed Sattar
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.